drug · gene
patient view →lovotibeglogene autotemcel
Phase 3updated 2mo agoby Genetix Biotherapeutics Inc🔗 ChEMBL
Phase 3community read0 votes
Gene drug with a maximum clinical stage of Approval, with an approval for sickle cell disease.
indications
indications
Sickle Cell Disease
targets
Hemoglobin subunit beta
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that